CancerConnect
Top Stories
Newly Diagnosed
Treatment & Care
Survivorship

The CancerConnect Myeloproliferative Neoplasms MPN Newsletter

MedMaven

Stay Current With PV, ET, MF Treatment Advances & Connect with Others

CancerConnect MPN Newsletter

CancerConnect publishes daily cancer news, original articles and "tips" on the management of ET, PV, and MF. These are available in our monthly MPN newsletter.

Stay Current - Connect With Other MPN Patients

Join The CancerConnect Community: Connect with others and receive regular updates

or

Sign up for the MPN Newsletter Here

Comments

Myeloproliferative Neoplasms MPN

FEATURED
COMMUNITY

Overview of Polycythemia Vera

Understand the symptoms, diagnosis, treatment & management of Polycythemia Vera.

Cancer Connect

New Treatment Strategies for Jakafi Experienced Patients with Myelofibrosis

Clinical trial results for novel Myelofibrosis treatments were updated at the 2019 Amer Soc Hematology meeting.

MedMaven

Momelotinib Granted FDA Fast Track Designation for Myelofibrosis

Momelotinib to begin clinical trial in individuals with Myelofibrosis

MedMaven

Idasanutlin Treatment for Polycythemia Vera and Essential Thrombocytopenia

Idasanutlin is active in the treatment of PV and ET and is currently being evaluated in a global phase 2 trial.

MedMaven

Thalidomide - Jakafi Combo A Novel Approach for Treatment of Myelofibrosis

Thalidomide - Jakafi Combination may be Effective for Treatment of Myelofibrosis Associated Low Blood Counts

MedMaven

by

kasongo

Long Term Survival in Myelofibrosis Improved with Early Use of Jakafi®

In addition to improving long term survival Jakafi® improves MF caused fatigue, spleenomegaly and kidney function.

Cancer Connect

by

aliraza32415

MPN Research Foundation-PV Reporter-Cancer Connect Create Combined Community

Leading cancer centers create combined social community with MPNRF PV Reporter & Cancer Connect to support MPN patients

Cancer Connect

Jakafi Superior to Standard Therapy for Polycythemia Vera

Jakafi superior symptom control, delays phlebotomy, and improves outcomes for individuals with Polycythemia Vera.

Cancer Connect

Ask the Expert Advances in the Management of Myeloproliferative Neoplasms

Dr. Ruben Mesa, Mays Cancer Center answered questions about the management of polycythemia vera and myelofibrosis.

TraceyS

Daurismo Evaluated in Myelofibrosis

AML drug Daurismo evaluated in MF - further study warranted.

MedMaven